Reducing anticholinergic medication exposure among older adults using consumer technology: Protocol for a randomized clinical trial.

ABSTRACT:

Introduction

A growing body of scientific evidence points to the potentially harmful cognitive effects of anticholinergic medications among older adults. Most interventions designed to promote deprescribing of anticholinergics have directly targeted healthcare professionals and have had mixed results. Consumer-facing technologies may provide a unique benefit by empowering patients and can complement existing healthcare professional-centric efforts.

Methods

We initiated a randomized clinical trial to evaluate the effectiveness of a patient-facing mobile application (Brain Safe app) compared to an attention control medication list app in reducing anticholinergic exposure among community-dwelling older adults. Study participants are adults aged 60 years and above, currently usi

SUBMITTER: Abebe E 

PROVIDER: S-EPMC8007932 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature